Inhibrx Announces Pricing of Initial Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Inhibrx (INBX) IPO Opens, Trades Higher
August 19, 2020 12:26 PM EDTToday's IPO for Inhibrx Inc. (NASDAQ: INBX) opened for trading earlier at $22.10 after pricing 7,000,000 shares of common stock at a price to the public of $17.00 per share. All of the shares of common stock are being offered by Inhibrx. Shares have continued higher to... More
